TAVT-45, an easy-to-swallow drug that can be suspended in water or juice, is being studied for the treatment of patients with metastatic prostate cancer. A new treatment for patients with prostate ...
TAVT-45, a drug that can be mixed with juice or water, showed similar efficacy in treating metastatic castration-resistant prostate cancer as Zytiga. Patients with metastatic castration-resistant ...
September marks Prostate Cancer Awareness Month. In Singapore, prostate cancer is the third most common cancer affecting men, according to statistics from National Cancer Centre Singapore (NCCS), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback